Markets

Stock Market Today: FDA Gives Stocks a Booster Shot

The FDA's emergency-use green light of a COVID-19 treatment helped give the major indices a lift Monday, with the Dow leading the way.

Enthusiasm for potential treatments for COVID-19 continued to boost stocks in this brand-new bull market.

The major indices were helped Monday by an Emergency Use Authorization from the Food and Drug Administration to use antibody-rich plasma from recovered COVID patients to treat serious cases in new patients – despite thin evidence so far of its efficacy.

Financial Times (paywall) also reported on Sunday that "the Trump administration is considering bypassing normal US regulatory standards to fast-track an experimental coronavirus vaccine from the UK for use in America ahead of the presidential election, according to three people briefed on the plan," but AstraZeneca (AZN) denied that report.

The S&P 500 (+1.0% to 3,431) and Nasdaq Composite (+0.6% to 11,379) both set record closing highs, and the small-cap Russell 2000 gained 1% to 1,568. The Dow Jones Industrial Average was the strongest of the major indices, gaining 1.4% to close at 28,308; it remains about 4% below its Feb. 12 all-time closing high.

Looking ahead: Dollar General (DG), Nordstrom (JWN) and Williams-Sonoma (WSM) are among the companies to watch out for in a retail-heavy earnings slate.

The Market's Heavy Tilt Continues

They say a rising tide lifts all boats, but that hasn't been precisely accurate this time around.

Despite Monday's "rotation" day that saw more cyclical sectors take the lead, technology (and tech-related) stocks with mega market values have done most of the lifting in boosting the major indices to record highs, even as many other stocks have delivered dismal returns.

"'Big tech' (how they’re generically compartmentalized) has been a powerful force. Rightly so, the dominance of the five largest stocks in the S&P 500 have received much investor attention (and buying pressure)," writes Liz Ann Sonders, Senior Vice President and Chief Investment Strategist at Charles Schwab, in recent market commentary. "In equal-weighted terms, they represent 1% of the S&P 500; but in cap-weighted terms, they now represent nearly their own quartile."

"That said, it would be in keeping with history for at least some short-term consolidation – which could simply take the form of a rotation away from the concentrated leadership areas vs. something more sinister. Most historical studies of similar periods of concentration show a tendency for flat-to-lower stock prices short-term; but higher prices longer-term."

That shouldn't put longer-term investors off the tried-and-true formula of buying cheap, market-tracking exchange-traded funds, but it's understandable if even generally conservative investors want to be a bit more tactical with their approach. Stock picking is back in fashion because of stark disparities in individual share performance this year. Individual asset classes and market sectors are leaving others behind in the pandemic's new normal.

One way to build a nimble but diversified portfolio aimed at weighting current winners over laggards is to gather up a variety of low-cost ETFs. Read on to discover Kiplinger's 20 favorite cheap ETFs that cover various facets of the market.

Most Popular

Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
The 12 Best Consumer Discretionary Stocks to Buy for 2022
stocks to buy

The 12 Best Consumer Discretionary Stocks to Buy for 2022

Consumer discretionary stocks may be among 2022's most challenging places to invest in. But these picks could overcome several sector headwinds.
January 4, 2022
How to Know When You Can Retire
retirement

How to Know When You Can Retire

You’ve scrimped and saved, but are you really ready to retire? Here are some helpful calculations that could help you decide whether you can actually …
January 5, 2022

Recommended

8 Facts You Need to Know About Stock Market Corrections
Markets

8 Facts You Need to Know About Stock Market Corrections

Scary as they are, drawdowns are a normal part of the investing process. Having a financial plan in place and sticking to it is every investor's best …
January 23, 2022
Stock Market Today (1/21/22): Nasdaq Sinks Again, Ends Worst Week Since 2020
Stock Market Today

Stock Market Today (1/21/22): Nasdaq Sinks Again, Ends Worst Week Since 2020

A negative earnings reaction for Netflix (NFLX) and options expiration sparked a volatile session for stocks.
January 21, 2022
Kiplinger's Weekly Earnings Calendar
stocks

Kiplinger's Weekly Earnings Calendar

Check out our earnings calendar for the upcoming week, as well as our previews of the more noteworthy reports.
January 21, 2022
Stock Market Today (1/20/22): Foiled Again! Sizable Snap-Back Fizzles Late
Stock Market Today

Stock Market Today (1/20/22): Foiled Again! Sizable Snap-Back Fizzles Late

The Nasdaq fell even further into correction territory Thursday after early gains collapsed in the afternoon.
January 20, 2022